文献速递神经肿瘤

靶向COL5A1通过抑制Wnt/β-catenin信号通路增强失巢凋亡从而减轻胶质母细胞瘤恶性程度

Targeting COL5A1 enhances anoikis thus attenuating malignancy of glioblastoma via inhibiting the Wnt/β-catenin signaling pathway.
PubMed 文献 · J Neurooncol · 2025-05-22

本研究利用TCGA、CGGA和MSigDB数据库筛选与胶质母细胞瘤(GBM)恶性程度及失巢凋亡相关的基因,鉴定出V型胶原α1链(COL5A1)与失巢凋亡及不良预后相关。体外和体内实验显示敲低COL5A1可显著降低GBM恶性程度,低附着培养下失巢凋亡显著增强。RNA测序分析提示COL5A1通过调控Wnt/β-catenin信号通路影响失巢凋亡和恶性程度。

要点

  • COL5A1被鉴定为与GBM失巢凋亡及不良预后相关的关键基因。
  • 敲低COL5A1在体外和体内均显著降低GBM恶性程度。
  • COL5A1通过调控Wnt/β-catenin信号通路影响失巢凋亡和GBM恶性程度。

核心结论

  • COL5A1通过调控Wnt/β-catenin信号通路影响GBM细胞的失巢凋亡和恶性程度,可能成为GBM新的预后相关生物标志物和潜在治疗靶点。

研究设计与样本

  • 利用TCGA、CGGA和MSigDB数据库鉴定与GBM恶性程度和失巢凋亡相关的基因,并通过增殖、侵袭和迁移实验在有附着和无附着条件下验证关键基因的作用,采用RNA测序分析揭示机制。

主要发现

  • COL5A1被鉴定为与失巢凋亡和不良结局相关的关键基因。
  • 敲低COL5A1在体外和体内均诱导GBM恶性程度显著降低。
  • 低附着细胞培养后,COL5A1表达降低使细胞失巢凋亡显著增强。
  • RNA测序分析显示敲低COL5A1后Wnt/β-catenin信号通路活性减弱。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: As one of the most prevalent primary brain tumors, glioblastoma (GBM) is characterized by its severe malignancy and extremely poor prognosis. Recent studies have demonstrated that targeting anoikis and malignancy showed impressed efficiency for treatment in a wide range of solid tumors, however, relevant research on GBM still remains unclarified. METHODS: In this study, genes related with malignancy and anoikis of GBM were identified by utilizing the Cancer Genome Atlas (TCGA), the Chinese Glioma Genome Atlas (CGGA) and the Molecular Signatures Database (MSigDB). Subsequently, the role of the key gene was validated via proliferation, invasion and migration experiments both in conditions with and without attachment. Moreover, RNA sequencing analysis was employed to reveal further mechanisms. RESULTS: Here, Type V collagen alpha 1 (COL5A1) was identified as a critical gene associated with anoikis and poor outcomes. Additionally, COL5A1 knockdown induced significant reduction in malignancy of GBM both in vitro and in vivo. Moreover, cell anoikis was remarkable enhanced by reduced expression of COL5A1 after low-attachment cell culture. Mechanically, RNA sequencing analysis revealed that the activity of the Wnt/β-catenin signaling pathway was diminished following COL5A1 knockdown, which indicated that COL5A1 reduced anoikis via regulating Wnt/β-catenin signaling pathway thus promoted malignancies of GBM cells. CONCLUSION: These findings demonstrated the novel evidence that COL5A1 serves as an essential regulatory factor influencing both anoikis and malignancy of GBM cells by regulating Wnt/β-catenin signaling pathway, indicating that COL5A1 could be a novel prognosis-related biomarker and potential therapeutic target for GBM.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Zhou M, Wu W, Wang Y, et al. Targeting COL5A1 enhances anoikis thus attenuating malignancy of glioblastoma via inhibiting the Wnt/β-catenin signaling pathway. J Neurooncol. 2025. PMID: 40402199. doi:10.1007/s11060-025-05036-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。